Search Results 8941-8950 of 42533 for oral

  1. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

    Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

  2. Liver Transplant Clinical Trials - Mayo Clinic Research

    This is an Open Label, Multicenter, pilot clinical trial to assess the efficacy and safety of an oral selective Endothelin Receptor Antagonist (ambrisentan) in ...

  3. Surgery - Doctors - Mayo Clinic

    Christopher F. Viozzi, M.D., D.D.S.. Oral and Maxillofacial Surgeon. Rochester, MN ...

  4. Surgery - Doctors - Mayo Clinic

    Oral and Maxillofacial Surgeon. Rochester, MN. Areas of focus: Jaw surgery, Cleft palate repair, Bone graft surgery, Maxillomandibular advancement surgery ...

  5. Sleep disorders - Doctors and departments - Mayo Clinic

    Davis, M.D.. Dermatologist. Rochester, MN. Areas of focus: Wound care, Patch test, Chronic hives, Erythromelalgia, Oral lichen planus, Dermatitis, Mixed ...

  6. Publications - Homan Mohammadi, M.D. - Mayo Clinic

    Oral Oncol. 2025 Jul; 166:107308 Epub 2025 May 17. View PubMed; Bakhtiar M, Ye Z, Schoenfeld JD, Mohammadi H, Guenette JP, Rettig EM, Hanna GJ, Kann BH ...

  7. Immunogenetics of COVID-19 Immune Response - Mayo Clinic

    Preventative use of antibiotics (i.e. oral surgery) is not an exclusion criterion. Diagnosis of a cognitive disorder (e.g., Alzheimer's, Dementia). Anemia ...

  8. hyperbaric oxygen therapy Archives - Mayo Clinic News Network

    ... oral cancer treatment left Mike Serpe in terrible pain and unable to eat or drink for months. But after coming to Mayo Clinic, where he began hyperbaric ...

  9. Safety And Efficacy Study Of Filgotinib, GS-9876 And Tirabrutinib In Adults With Active Sjogren's Syndrome - Mayo Clinic

    Stable dose (defined as no change in prescription for at least 4 weeks prior to Day 1) of NSAIDs, HCQ, MTX and/or oral corticosteroids is permitted during ...

  10. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    Patients unable to take any prophylaxis are not eligible. Life expectancy ≥6 months; Ability to swallow oral medications. Exclusion Criteria: This study ...